Greetings, The shortest distance between two points ... or the clinical use of improved agents against lymphoma is the efficient enrollment in clinical trials...
This enlightening article by Ralph Moss is especially relevant to blood cancers. (andy) Personalized Oncology? Sunday, 08 November 2009 The latest buzzword in...
Originally published as JCO Early Release 10.1200/JCO.2008.21.1169 on October 5 2009 Journal of Clinical Oncology, Vol 27, No 32 (November 10), 2009: pp....
Originally published as JCO Early Release 10.1200/JCO.2009.22.1291 on October 13 2009 Journal of Clinical Oncology, Vol 27, No 32 (November 10), 2009: pp....
Good morning, This for-profit group helps patients to participate in lymphoma trials as described. http://www.pharmatechoncology.com:80/patients/lymphoma ...
(Haematologica 2009, 10.3324/haematol.2009.011767) The utility of a prognostic index for predicting time to first treatment (TFT) in early chronic lymphocytic...
Preliminary data on the involvement of B, C and D hepatitis viruses in the etiopathogenesis of chronic lymphoproliferative syndromes in Romania. V Molagic, V...
Copying from Cancer Myths: "Cancer surgery causes tumors to spread. Surgery is an effective type of cancer treatment. And although it's possible that the...
Below are reusable queries to locate studies that include genetic analysis. "Genetic analysis" generally means the evaluation of biospecimen (tumor or other)...
Re: Wendy Harpham on The Art of Survivorship Anjou wrote: Fabulous show-- worth a listen @ http://bit.ly/4vYgWf Indeed! Direct link to recorded interview...
Just listening now. Inspirational, for anyone ... == Of the webcast with Wendy Harpham on the Art of Survivorship, Anjou writes: "Fabulous show, worth a...
From Anjou FYI Subject: [nhl-info] talking science with patient advocates Laurie: There is a schism between ardent supporters of evidence-based medicine and...
A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia 1.. Daphne R. Friedman1,2, 2.. J. Brice Weinberg1,4, ...
Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Non-Hodgkin's Lymphoma (Follicular, Diffuse Large Cell, Mantle...
Vegetarians have less cancers In the last issue of icon we told you that meat caused inflammation in the body, and inflammation was a known precursor to...
A Victory for Hyperthermia in Bladder Cancer Sunday, 15 November 2009 There was another victory for the use of regional deep hyperthermia in the treatment of...
Prudent guidelines for adults as well when in treatment or if immune suppressed. ~ Karl == The Effectiveness of the Neutropenic Diet in Pediatric Cancer ...
Thanks. Just a note that results with regional deep hyperthermia is not likely to be applicable for a systemic (i.e., blood) cancer. Karl A Victory for...
Here's the source report: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699384/?tool=pmcentrez Seems an important finding in that it was a prospectively ...
Greetings, Occupational studies have been done on dental health professionals ...those presumably exposed to mercury vapors at the highest levels ... and no...
This study is not recruiting, but worth calling attention to. Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously...
This I expect would apply to CNS-lymphoma, primary or secondary http://bit.ly/3s8M9k All the best, ~ Karl Patients Against Lymphoma Patients Helping Patients ...
Early but interesting. == New Drug Blocks "Undruggable" Target in Cancer Cells http://www.cancer.gov/ncicancerbulletin/111709/page3 Researchers have created a...
Encouaging results, but n is too small Preliminary Results of a Phase II Study of Lenalidomide and Rituximab in Relapsed / Refractory Indolent Non-Hodgkin's...
Published online first on November 17, 2009 [Cancer Research, 10.1158/0008-5472.CAN-09-2604] A Novel Paradigm to Trigger Apoptosis in Chronic Lymphocytic...
Blood First Edition Paper, prepublished online November 17, 2009; DOI 10.1182/blood-2009-08-236471. Submitted August 10, 2009; accepted October 26, 2009. ...